152 related articles for article (PubMed ID: 36547172)
21. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
[TBL] [Abstract][Full Text] [Related]
22. Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy.
Lee CK; Jung M; Jung I; Heo SJ; Jeong YH; An JY; Kim HI; Cheong JH; Hyung WJ; Noh SH; Kim HS; Rha SY; Chung HC
Ann Surg; 2016 Jan; 263(1):96-102. PubMed ID: 25575260
[TBL] [Abstract][Full Text] [Related]
23. Association of sentinel lymph node biopsy with survival for head and neck melanoma: survival analysis using the SEER database.
Sperry SM; Charlton ME; Pagedar NA
JAMA Otolaryngol Head Neck Surg; 2014 Dec; 140(12):1101-9. PubMed ID: 25321889
[TBL] [Abstract][Full Text] [Related]
24. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.
He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC
Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968
[TBL] [Abstract][Full Text] [Related]
25. Metformin confers risk reduction for developing hepatocellular carcinoma recurrence after liver resection.
Chan KM; Kuo CF; Hsu JT; Chiou MJ; Wang YC; Wu TH; Lee CF; Wu TJ; Chou HS; Lee WC
Liver Int; 2017 Mar; 37(3):434-441. PubMed ID: 27775209
[TBL] [Abstract][Full Text] [Related]
26. The safety of and indications for immediate reconstruction of head and neck melanoma defects: our early experience.
Parrett BM; Kashani-Sabet M; Leong SP; Buncke N; Singer MI
Ann Plast Surg; 2014 May; 72 Suppl 1():S35-7. PubMed ID: 24691340
[TBL] [Abstract][Full Text] [Related]
27. Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale.
Casadei Gardini A; Faloppi L; De Matteis S; Foschi FG; Silvestris N; Tovoli F; Palmieri V; Marisi G; Brunetti O; Vespasiani-Gentilucci U; Perrone G; Valgiusti M; Granato AM; Ercolani G; Negrini G; Tamburini E; Aprile G; Passardi A; Santini D; Cascinu S; Frassineti GL; Scartozzi M
Eur J Cancer; 2017 Nov; 86():106-114. PubMed ID: 28985579
[TBL] [Abstract][Full Text] [Related]
28. Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin.
Berstein LM; Boyarkina MP; Teslenko SY
Med Oncol; 2012 Jun; 29(2):1308-13. PubMed ID: 21298495
[TBL] [Abstract][Full Text] [Related]
29. Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?
Barbour S; Mark Smithers B; Allan C; Bayley G; Thomas J; Foote M; Burmeister B; Barbour AP
Ann Surg Oncol; 2015 Nov; 22(12):4052-9. PubMed ID: 25582744
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of metformin for non-small cell lung cancer patients with diabetes.
Xu T; Li D; He Y; Zhang F; Qiao M; Chen Y
World J Surg Oncol; 2018 Mar; 16(1):60. PubMed ID: 29558957
[TBL] [Abstract][Full Text] [Related]
31. The Effect of Metformin on Survival Outcomes of Non-Metastatic Breast Cancer Patients with Type 2 Diabetes.
Behrouzi B; Zokaasadi M; Mohagheghi MA; Emami AH; Sadighi S
Asian Pac J Cancer Prev; 2021 Feb; 22(2):611-616. PubMed ID: 33639681
[TBL] [Abstract][Full Text] [Related]
32. Metformin use associated with lower risk of cancer in patients with diabetes mellitus type 2.
Kusturica J; Kulo Ćesić A; Gušić E; Maleškić S; Rakanović-Todić M; Šečić D
Med Glas (Zenica); 2017 Aug; 14(2):176-181. PubMed ID: 28698536
[TBL] [Abstract][Full Text] [Related]
33. Prognosis of small cell lung cancer patients with diabetes treated with metformin.
Xu T; Liang G; Yang L; Zhang F
Clin Transl Oncol; 2015 Oct; 17(10):819-24. PubMed ID: 26063645
[TBL] [Abstract][Full Text] [Related]
34. Effect of metformin on the incidence of head and neck cancer in diabetics.
Yen YC; Lin C; Lin SW; Lin YS; Weng SF
Head Neck; 2015 Sep; 37(9):1268-73. PubMed ID: 24801563
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
Saka Herrán C; Jané-Salas E; Estrugo Devesa A; López-López J
Oral Oncol; 2018 Oct; 85():68-81. PubMed ID: 30220322
[TBL] [Abstract][Full Text] [Related]
36. Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study.
Wang SB; Lei KJ; Liu JP; Jia YM
Medicine (Baltimore); 2017 Jul; 96(29):e7605. PubMed ID: 28723808
[TBL] [Abstract][Full Text] [Related]
37. Impact of diabetes mellitus on oncological outcomes after radical hysterectomy for early stage cervical cancer.
Jiamset I; Hanprasertpong J
J Gynecol Oncol; 2016 May; 27(3):e28. PubMed ID: 27029749
[TBL] [Abstract][Full Text] [Related]
38. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
[TBL] [Abstract][Full Text] [Related]
39. The impact of metformin on survival in patients with melanoma-national cohort study.
Urbonas V; Rutenberge J; Patasius A; Dulskas A; Burokiene N; Smailyte G
Ann Epidemiol; 2020 Dec; 52():23-25. PubMed ID: 32980534
[TBL] [Abstract][Full Text] [Related]
40. The Association between Metformin and Survival of Head and Neck Cancer: A Systematic Review and Meta-Analysis of 7 Retrospective Cohort Studies.
Wang Y; Fu T; Liu Y; Yang G; Yu C; Zhang ZJ
Curr Pharm Des; 2020; 26(26):3161-3170. PubMed ID: 32067604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
